Please login to the form below

Not currently logged in
Email:
Password:

Pfizer launches pharmacy initiative in Nigeria

Pfizer launches a new project to empower community pharmacies across Nigeria to provide access to quality drugs, information and health screening for patients

According to local media reports, US pharmaceutical giant Pfizer has launched a new project to empower community pharmacies across Nigeria to provide access to quality drugs, information and health screening for patients.

The Pfizer programme provides selected pharmacies with regular free training for their staff and provides with strips and re-agents to conduct free cardiovascular testing.

The pharmacies would also be supplied with free disease awareness educational materials while also enjoying the company's special discount per volume plan on products and product-based discounts and other promotions.

The project is aimed at combating counterfeits and parallel imports, which are rife on the Nigerian pharma market. The Pfizer-Friendly Pharmacies, as branded pharmacies, would be assisted to stock only genuine Pfizer products, so members of the public will see them as places where quality products can be obtained.

The project may be a way for Pfizer to improve its reputation locally, as it is currently involved in a legal battle with the Abuja division of the Nigerian Federal high court regarding clinical trials of an anti-infective conducted in Kano state in 1996.

The Nigerian government had charged Pfizer with alleged criminal application of Trovan (trovafloxacin) on 200 Nigerian children. The drug, it is alleged, killed many of the children and left others with various permanent disabilities.

14th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...